Macquarie Group LTD Emergent Bio Solutions Inc. Transaction History

Macquarie Group LTD

$90.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.86 - $6.98 $4,984 - $18,706	2,680 New	2,680 $18,000
Q3 2022 Nov 14, 2022	SELL	$20.09 - $35.8 $11,290 - $20,119	-562 Reduced 54.72%	465 $22,000
Q4 2021 Feb 11, 2022	SELL	$33.11 - $55.01 $844,139 - $1.4 Million	-25,495 Reduced 96.13%	1,027 $45,000
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $107,615 - $152,954	1,901 Added 7.72%	26,522 $1.67 Million
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $241,271 - $350,281	2,798 Added 12.82%	24,621 $2.29 Million
Q4 2020 Feb 16, 2021	BUY	$79.17 - $111.47 $184,307 - $259,502	2,328 Added 11.94%	21,823 $1.96 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $629,396 - $1.04 Million	-7,684 Reduced 28.27%	19,495 $2.01 Million
Q2 2020 Aug 11, 2020	SELL	$54.33 - $89.52 $53,406 - $87,998	-983 Reduced 3.49%	27,179 $2.15 Million
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $208,658 - $290,786	-4,229 Reduced 13.06%	28,162 $1.63 Million
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $146,255 - $168,675	2,856 Added 9.67%	32,391 $1.75 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $55,175 - $77,734	-1,359 Reduced 4.4%	29,535 $1.54 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $144,031 - $194,326	3,608 Added 13.22%	30,894 $1.49 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $173,628 - $238,176	3,600 Added 15.2%	27,286 $1.38 Million
Q4 2018 Feb 15, 2019	SELL	$55.63 - $73.24 $170,895 - $224,993	-3,072 Reduced 11.48%	23,686 $1.4 Million
Q3 2018 Nov 15, 2018	SELL	$52.05 - $66.51 $244,582 - $312,530	-4,699 Reduced 14.94%	26,758 $1.76 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $62,684 - $72,165	1,297 Added 4.3%	31,457 $1.59 Million
Q1 2018 May 11, 2018	SELL	$44.44 - $54.39 $394,049 - $482,276	-8,867 Reduced 22.72%	30,160 $1.59 Million
Q4 2017 Feb 15, 2018	SELL	$37.77 - $47.75 $96,162 - $121,571	-2,546 Reduced 6.12%	39,027 $1.81 Million
Q3 2017 Nov 08, 2017	BUY	$34.14 - $40.45 $1.42 Million - $1.68 Million	41,573	41,573 $1.68 Million

Others Institutions Holding EBS

# of Institutions

159

Shares Held

33.7M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.9 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$29.1 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21.4 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$19.1 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.4 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $427M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account